51ÁÔÆæ

Please note that functional cookies must be enabled to listen to a podcast.

In this episode of 51ÁÔÆæ Radio, host, Brandon Miller, and 51ÁÔÆæ Executive VP of Pharmaceuticals, Steven Lynn, go over how 51ÁÔÆæ helped an international company perform a gap analysis based on multiple FDA investigations.

Listen in as we break down the client’s Warning Letter Remediation challenges, 51ÁÔÆæ’s approach to remediation, the ongoing work still taking place, and some advice on FDA Investigation Readiness.

To begin the 51ÁÔÆæ scoping process today, please enter your information in the blue form below and click the submit button at the bottom of the webpage.